NO985365L - Karbohydratderivater - Google Patents

Karbohydratderivater

Info

Publication number
NO985365L
NO985365L NO985365A NO985365A NO985365L NO 985365 L NO985365 L NO 985365L NO 985365 A NO985365 A NO 985365A NO 985365 A NO985365 A NO 985365A NO 985365 L NO985365 L NO 985365L
Authority
NO
Norway
Prior art keywords
carbohydrate derivatives
carbohydrate
derivatives
Prior art date
Application number
NO985365A
Other languages
English (en)
Other versions
NO985365D0 (no
NO310723B1 (no
Inventor
Constant Adriaan Anton Boeckel
Maurice Petitou
Philippe Duchaussoy
Johannes Egbertus Maria Basten
Cornelia Maria Dreef-Tromp
Original Assignee
Akzo Nobel Nv
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Sa filed Critical Akzo Nobel Nv
Publication of NO985365D0 publication Critical patent/NO985365D0/no
Publication of NO985365L publication Critical patent/NO985365L/no
Publication of NO310723B1 publication Critical patent/NO310723B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO19985365A 1997-11-19 1998-11-18 Karbohydratderivater NO310723B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203613 1997-11-19

Publications (3)

Publication Number Publication Date
NO985365D0 NO985365D0 (no) 1998-11-18
NO985365L true NO985365L (no) 1999-05-20
NO310723B1 NO310723B1 (no) 2001-08-20

Family

ID=8228942

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985365A NO310723B1 (no) 1997-11-19 1998-11-18 Karbohydratderivater

Country Status (34)

Country Link
US (1) US6174863B1 (no)
EP (1) EP1032579B1 (no)
JP (1) JP4364959B2 (no)
KR (1) KR100518497B1 (no)
CN (1) CN1177855C (no)
AR (1) AR017640A1 (no)
AT (1) ATE239030T1 (no)
AU (1) AU746959B2 (no)
BR (1) BRPI9804699B1 (no)
CA (1) CA2253113C (no)
CO (1) CO4990974A1 (no)
CZ (1) CZ293639B6 (no)
DE (1) DE69814140T2 (no)
DK (1) DK1032579T3 (no)
EE (1) EE04348B1 (no)
ES (1) ES2198081T3 (no)
HK (1) HK1028406A1 (no)
HU (1) HU226685B1 (no)
ID (1) ID21287A (no)
IL (1) IL126893A (no)
IS (1) IS2527B (no)
NO (1) NO310723B1 (no)
NZ (1) NZ332834A (no)
PE (1) PE134799A1 (no)
PL (1) PL188229B1 (no)
PT (1) PT1032579E (no)
RU (1) RU2210573C2 (no)
SG (1) SG72889A1 (no)
SK (1) SK284134B6 (no)
TR (1) TR199802372A2 (no)
TW (1) TW448180B (no)
UA (1) UA49089C2 (no)
WO (1) WO1999025720A1 (no)
ZA (1) ZA9810559B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI289566B (en) * 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
EP1353556A4 (en) * 2001-01-23 2009-09-09 Massachusetts Inst Technology SYNTHESIS OF HEPARIN AND OTHER GLYCOSAMINOGLYCANS IN SOLID PHASE AND SOLUTION PHASE
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
CN1317287C (zh) * 2003-04-18 2007-05-23 山东大学 一种多硫酸寡糖及其制备方法
KR101156273B1 (ko) * 2004-03-04 2012-06-13 프로젠 파마슈티칼즈 리미티드 황산화 올리고사카라이드 유도체
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
US20110150976A1 (en) * 2008-09-10 2011-06-23 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
CA2777099C (en) 2009-07-31 2018-03-27 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
CN103917552B (zh) * 2011-06-17 2017-03-29 卡博梅麦特斯公司 具有短半衰期和高活性的合成五糖
EP2578594A1 (en) 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
US9873712B2 (en) 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
WO2021043631A1 (en) 2019-09-02 2021-03-11 Hepoligo Solutions Aps Intermediates useful for preparing iduronic acid containing di- and polysaccharides
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
ES2060284T3 (es) * 1990-04-23 1994-11-16 Sanofi Elf Un procedimiento para la preparacion de un derivado de carbohidrato que comprende una unidad de trisacarido.
IL102758A (en) * 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
SK7362000A3 (en) 2000-10-09
AR017640A1 (es) 2001-09-12
EP1032579B1 (en) 2003-05-02
BRPI9804699B1 (pt) 2016-07-12
KR100518497B1 (ko) 2005-12-16
AU9324298A (en) 1999-06-17
EE04348B1 (et) 2004-08-16
CN1177855C (zh) 2004-12-01
CA2253113C (en) 2008-06-17
IL126893A0 (en) 1999-09-22
HUP9802663A2 (hu) 1999-06-28
HUP9802663A3 (en) 2000-04-28
ZA9810559B (en) 1999-05-15
CZ293639B6 (cs) 2004-06-16
CZ376198A3 (cs) 1999-06-16
HU226685B1 (en) 2009-06-29
CN1222524A (zh) 1999-07-14
BR9804699A (pt) 2000-12-26
HU9802663D0 (en) 1999-01-28
UA49089C2 (uk) 2002-09-16
DE69814140D1 (de) 2003-06-05
EP1032579A1 (en) 2000-09-06
IL126893A (en) 2003-05-29
DK1032579T3 (da) 2003-08-25
SK284134B6 (sk) 2004-09-08
NO985365D0 (no) 1998-11-18
US6174863B1 (en) 2001-01-16
TW448180B (en) 2001-08-01
DE69814140T2 (de) 2004-04-08
PL329789A1 (en) 1999-05-24
NO310723B1 (no) 2001-08-20
TR199802372A2 (xx) 1999-06-21
CA2253113A1 (en) 1999-05-19
JPH11217394A (ja) 1999-08-10
WO1999025720A1 (en) 1999-05-27
PL188229B1 (pl) 2004-12-31
JP4364959B2 (ja) 2009-11-18
ATE239030T1 (de) 2003-05-15
NZ332834A (en) 2000-01-28
HK1028406A1 (en) 2001-02-16
CO4990974A1 (es) 2000-12-26
ES2198081T3 (es) 2004-01-16
AU746959B2 (en) 2002-05-09
SG72889A1 (en) 2000-05-23
ID21287A (id) 1999-05-20
PT1032579E (pt) 2003-08-29
EE200000301A (et) 2001-12-17
KR19990045312A (ko) 1999-06-25
IS5485A (is) 2000-05-09
RU2210573C2 (ru) 2003-08-20
IS2527B (is) 2009-07-15
PE134799A1 (es) 2000-01-07

Similar Documents

Publication Publication Date Title
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
DE69817186D1 (de) Diaminorhodamin-derivate
ATE393145T1 (de) Pyridinderivate
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
PT915088E (pt) Derivados de d-prolina
NO20000231D0 (no) Dolastatin-15-derivater
ATE255098T1 (de) Substituierte chromanderivate
PT1003719E (pt) Derivados microbicidas de n-sulfonil-glicinalquiniloxifenemetilamida
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
DE69814140D1 (de) Kohlenhydrat-derivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE255099T1 (de) Substituierte chromanderivate
ATE231508T1 (de) Azyklische nukleosidderivate
DK0818459T3 (da) Carbonhydrat-derivater
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater
DK0966437T3 (da) 5-Aroylnaphthalenderivater
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
BR9605988A (pt) Derivados da carboestirila
NO993562L (no) Gemcitabine derivater
DE69825852D1 (de) Riboflavin Glucosid
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees